Jump to content

Verily

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Lentower (talk | contribs) at 11:46, 17 January 2016 (→References: add 30em to vary number of coumns based on window width). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Verily
FormerlyGoogle Life Sciences (Life science division of GoogleX)
Company typeSubsidiary of Alphabet
Industry
Key people
Andrew Conrad (CEO)
ParentAlphabet Inc.
SubsidiariesLift Labs
Websiteverily.com

Verily (formerly Google Life Sciences[1][2]) is Alphabet Inc.'s research organization devoted to the study of life sciences. The organization was formerly a division of Google X, until 10 August 2015 when Sergey Brin announced that the organization would become an independent subsidiary of Alphabet Inc.[3] This restructuring process was completed on October 2, 2015. On December 7, 2015, Google Life Sciences was renamed Verily.[4][5]

Researchers

As of July 2014, members of the research team include Andrew Conrad, founder of LabCorp's National Genetics Institute; Vik Bajaj, an expert in nuclear magnetic resonance; Marija Pavlovic, who studies the effect of radiation on DNA; Alberto Vitari, a cancer biologist; Brian Otis, who worked on Google Venture's glucose-sensing contact lens;[6] and Mark DePristo, who worked on the GATK at the Broad Institute.[7] Dr. Thomas R. Insel announced on Sept. 15, 2015, that he was resigning as the director of the National Institute of Mental Health (NIMH) to join this division.[1]

Acquisitions

On 9 September 2014, the division acquired Lift Labs, the makers of Liftware.[8]

Projects

  • Contact lenses that allow people with diabetes to continually check their glucose levels using a non-intrusive method.[9]
  • A spoon for people with tremors.[10]
  • The Baseline Study, a project to collect genetic and molecular information from enough people to create a picture of what a healthy human should be.[11]
  • A disease-detecting nanoparticle platform.[12]
  • A health-tracking wristband.[13]

See also

References

  1. ^ a b http://www.nih.gov/about/director/09152015_statement_insel.htm
  2. ^ Carey, Benedict. "Head of Mental Health Institute Leaving for Google Life Sciences". New York Times.
  3. ^ Brin, Sergey. "Google+ Post".
  4. ^ "Google Life Sciences debuts a new name, Verily". STAT. Retrieved 2015-12-07.
  5. ^ https://www.youtube.com/watch?v=Lyv0_GIGSbY, retrieved 2015-12-07 {{citation}}: Missing or empty |title= (help)
  6. ^ Barr, Alistair (Jul 25, 2014). "Meet the Google X Life Sciences Team". blogs.wsj.com. Retrieved 13 September 2014.
  7. ^ linkedin profile https://www.linkedin.com/in/markdepristo. {{cite web}}: Missing or empty |title= (help)
  8. ^ Chowdhry, Amit (10 September 2014). "Google Continues To Build Upon Its Life Sciences Ecosystem". forbes.com. Retrieved 13 September 2014.
  9. ^ Brian Otis; Babak Parviz (2014-01-16). "Introducing our smart contact lens project". Google. Retrieved 2014-01-17.
  10. ^ Rushe, Dominic (2014-11-25). "Google launches 'smart' spoon to help steady shaking hands". The Guardian. Retrieved 25 November 2014.
  11. ^ Kaiser, Jocelyn (28 July 2014). "Google X sets out to define healthy human | Science/AAAS | News". news.sciencemag.org. Retrieved 13 September 2014.
  12. ^ Gibbs, Samuel (29 October 2014). "Google is developing a cancer and heart attack-detecting pill". The Guardian. Retrieved 20 January 2015.
  13. ^ Chen, Caroline (23 June 2015). "Google Reveals Health-Tracking Wristband". Bloomberg. Retrieved 24 June 2015.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Verily&oldid=700257194"